FileDescriptionFile size
Download this file (HTL New Products Announcement 10-30-17 FINAL.PDF)30-October-2017-Press-Release.pdfHamilton Thorne Announces Expanded Product Offerings to Serve the Assisted Reproductive Technologies Market261 kB


HT to Showcase its Enhanced Range of Products at the ASRM Annual Meeting in San Antonio, Texas  from October 30 to November 1, 2017

BEVERLY, MA and TORONTO, Ontario – October 30, 2017 - Hamilton Thorne Ltd. (TSX-V:HTL), a leading world-wide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it has substantially expanded the range of products that it will offer to the ART market on a direct sales basis in North America.

David Wolf, President and Chief Executive Officer stated, “We are pleased to announce the next step in Hamilton Thorne’s capabilities as a full-service provider of products and services to the IVF laboratory. Coupled with the introduction of several products from our own family of companies, we are also announcing that we will be supporting a selection of best-in-class equipment and consumables to enable standardization of best practices in the laboratory.”

Keith Edwards, Senior Vice President and General Manager of Hamilton Thorne, Inc, added, “In order to provide our customers in the United States, Canada & Latin American markets with robust sales and support coverage, we have doubled our sales force and support team over the last few months. With our expanded direct sales and support team working in conjunction with our channel partners, we are now uniquely positioned to provide our customers in North America with the broadest array of product, service, support and purchasing options.”

In addition to its own line of precision lasers and image analysis systems, Hamilton Thorne will now offer the following products:

Gynemed Glass Micropipettes – Hamilton Thorne is introducing a complete line of Gynemed branded ICSI, holding and biopsy micropipettes. Each pipette is precision-made in Germany to exacting specifications and individually serialized for the ultimate traceability and quality.

Hamilton Thorne TrakJectorTM Micromanipulation System – Hamilton Thorne is introducing its new Hamilton Thorne branded TrakJector Micromanipulator System. This newly developed system is made in Germany and offers a unique control system for fast and accurate ICSI and biopsy procedures.

Hamilton Thorne DuraSlides™ Reusable Chambers – Hamilton Thorne’s DuraSlides represent the next dimension in durable, re-usable counting chambers. DuraSlides come in three configurations: gridded counting chambers of 10-micron and 20-micron depths for manual counting and a special DuraSlide CASA for use with Hamilton Thorne’s IVOS and CEROS analysis systems.

Planer CT37stax Incubator and Monitoring System – The innovative space saving design of the CT37stax multi-chamber benchtop incubator provides the optimal environment for culturing embryos in the IVF lab. Its unique design affords the highest dish capacity of any benchtop incubator currently available while needing 30% less space in a laboratory.

CELL-VU® Slides – Cell-VU’s industry leading microscope slides for sperm analysis include the CELL-VU Sperm Counting Chamber, the CELL-VU CBC Disposable Hemacytometer and Pre-Stained Morphology Slides.

Halosperm® DNA Fragmentation Kits – Halosperm is the leading in vitro diagnostic kit for measurement of DNA fragmentation in a fast, easy, and reproducible manner. Hamilton Thorne’s CASA systems offer its unique DNA Frag module to automate the use of the Halosperm kit in the research setting.

Panasonic Incubators – The Panasonic CytoGROW MCO-5M-PA multigas (CO2/O2) incubator is designed for precision, uniformity and repeatability of in vitro conditions. The compact, stackable design maximizes lab space and is ideal for individual cell culturing and IVF applications.

ZEISS Microscopes – The ZEISS family of stereoscopic, upright and inverted microscopes provide superior image quality and reliability for delicate IVF procedures, at a competitive price.

SAFE Sens® TrakStation® and TrakPod® – SAFE Sens offers continuous, non-invasive and calibration free pH monitoring systems of embryo culture media in large format and benchtop incubators. The TrakStation connects up to eight TrakPods, which automatically and continuously measure pH without having to remove samples from the incubator(s).

Please visit Hamilton Thorne at booth number 807 at the ASRM annual meeting from October 30 to November 1, 2017 at ASRM in San Antonio, Texas to see our new products and meet the newest members of our growing team.

Note: Not all products are available in all markets

About Hamilton Thorne Ltd. (

Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.

Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.

Certain information in this press release may contain forward-looking statements. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available at

For more information, please contact:

David Wolf, President & CEO
Hamilton Thorne Ltd.    
ir [AT] hamiltonthorne [DOT] com
Michael Bruns, CFO
Hamilton Thorne Ltd. 
ir [AT] hamiltonthorne [DOT] com

Subscribe to Our Investor Email List